The Pharmacy Times® Eye Care Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of eye diseases and conditions, including age-related macular degeneration, cataract, diabetic retinopathy, and glaucoma.
September 5th 2025
Pavblu, a biosimilar to Eylea, also showed no clinically meaningful differences in efficacy, safety, and immunogenicity in patients with neovascular age-related macular degeneration (nAMD).
Medications May Be Less Effective Outside Clinical Trials for Glaucoma Patients
May 15th 2014Although clinical trials have indicated that intraocular pressure-lowering medications are effective in patients with open-angle glaucoma, new research suggests that the medications may not be as effective in real-world settings.
Read More
Task Force Indecisive on Glaucoma Screening Recommendation
July 31st 2013Based on a review of studies on the risks and benefits of early screening and treatment for glaucoma, the United States Preventive Services Task Force concluded that it could not recommend for or against screening for asymptomatic adults.
Read More